VIVO Biobank cancer samples to be used in three new CCLG research projects
CCLG: The Children & Young People’s Cancer Association has funded three new solid tumour research projects.
Fundraising in memory of kind-hearted Arnos Grove schoolboy supports new childhood cancer research
An Arnos Grove family’s fundraising in memory of their six-year-old son has helped fund four new research projects into childhood leukaemia.
CCLG Special Named Funds support new collaboration with VIVO biobank
CCLG: The Children & Young People’s Cancer Association has funded two research projects that will support the development of kinder and more effective treatments for children and young people with acute myeloid leukaemia (AML).
Could prehabilitation help children get ready for tough treatments?
Bone marrow transplants put a huge strain on a child's body. But what if there was a way to prepare patients and improve recovery?
Mapping childhood cancer research: CCLG launches vital new report on UK research funding
CCLG: The Children & Young People’s Cancer Association has published a new report revealing major gaps in childhood cancer research funding, despite strong investment in treatment development.
Leading charity reveals major gaps in UK childhood cancer research funding
A new charity report has revealed major gaps in childhood cancer research funding despite strong investment in treatment development.
Mansfield family’s fundraising in memory of “kind and brave” 11-year-old fuels childhood leukaemia research
A Mansfield family’s fundraising in memory of their 11-year-old son and brother has helped fund two new research projects into childhood acute myeloid leukaemia (AML).
Kent auntie’s fundraising in nephew’s memory supports new childhood leukaemia research
A Staplehurst lady’s fundraising in memory of her “cheeky, mischievous” three-year-old nephew has helped support vital new childhood cancer research.
Surprising science - how diabetes drugs could treat childhood leukaemia
New cancer treatments take a long time and a lot of money to develop. So, what if we could use existing drugs from other conditions to kill cancer cells?